The plasmodium vivax merozoite surface protein 1 paralog is a novel erythrocyte-binding ligand of p. vivax

Infection and Immunity

Volumn 81, Issue 5, 2013, Pages 1585-1595

  Cheng, Yang ^a   Wang, Yue ^a,d   Ito, Daisuke ^b   Kong, Deok Hoon ^a   Ha, Kwon Soo ^a   Chen, Jun Hu ^a,e   Lu, Feng ^a,f   Li, Jian ^a,f   Wang, Bo ^a   Takashim, Eizo ^a,b   Sattabongkot, Jetsumon ^c   Tsuboi, Takafumi ^b   Han, Eun Taek ^a  

^a Kangwon National University   (South Korea)

^b EHIME UNIVERSITY   (Japan)

^c MAHIDOL UNIVERSITY   (Thailand)

^d INSTITUTE OF MATERIA MEDICA   (China)

^e CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^f JIANGSU INSTITUTE OF PARASITIC DISEASES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; IMMUNOGLOBULIN G; MEMBRANE ANTIGEN; MEROZOITE SURFACE PROTEIN 1; RECOMBINANT PROTEIN; VACCINE;

ADAPTIVE IMMUNITY; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGENICITY; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CHROMOSOME 7; CONTROLLED STUDY; ERYTHROCYTE; GAMETOCYTE; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; IMMUNOGENICITY; IN VITRO STUDY; LIGAND BINDING; MEROZOITE; MOLECULAR WEIGHT; NONHUMAN; OPEN READING FRAME; PARALOGY; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PREVALENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SCHIZONT;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ERYTHROCYTES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNOGLOBULIN G; MALARIA VACCINES; MALARIA, VIVAX; MALE; MEROZOITE SURFACE PROTEIN 1; MICE; MICE, INBRED BALB C; MIDDLE AGED; PLASMODIUM VIVAX; RECOMBINANT PROTEINS; YOUNG ADULT;

EID: 84877818855     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01117-12     Document Type: Article

References (45)

1. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, del Portillo HA. 2009. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect. Dis. 9:555-566.
2. Gaur D, Mayer DC, Miller LH. 2004. Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites. Int. J. Parasitol. 34:1413-1429.
3. Cowman AF, Crabb BS. 2006. Invasion of red blood cells by malaria parasites. Cell 124:755-766.
4. Miller LH, Mason SJ, Clyde DF, McGinniss MH. 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 295:302-304.
5. Menard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, Ratsimbasoa A, Thonier V, Carod JF, Domarle O, Colin Y, Bertrand O, Picot J, King CL, Grimberg BT, Mercereau-Puijalon O, Zimmerman PA. 2010. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc. Natl. Acad. Sci. U. S. A. 107:5967-5971.
6. Mendes C, Dias F, Figueiredo J, Mora VG, Cano J, de Sousa B, do Rosario VE, Benito A, Berzosa P, Arez AP. 2011. Duffy negative antigen is no longer a barrier to Plasmodium vivax-molecular evidences from the African West Coast (Angola and Equatorial Guinea). PLoS Negl. Trop. Dis. 5:e1192.
7. Gilson PR, Nebl T, Vukcevic D, Moritz RL, Sargeant T, Speed TP, Schofield L, Crabb BS. 2006. Identification and stoichiometry of glycosylphosphatidylinositol-anchored membrane proteins of the human malaria parasite Plasmodium falciparum. Mol. Cell. Proteomics 5:1286-1299.
8. Wang L, Mohandas N, Thomas A, Coppel RL. 2003. Detection of detergent-resistant membranes in asexual blood-stage parasites of Plasmodium falciparum. Mol. Biochem. Parasitol. 130:149-153.
9. Sanders PR, Gilson PR, Cantin GT, Greenbaum DC, Nebl T, Carucci DJ, McConville MJ, Schofield L, Hodder AN, Yates JR, III, Crabb BS. 2005. Distinct protein classes including novel merozoite surface antigens in Raft-like membranes of Plasmodium falciparum. J. Biol. Chem. 280: 40169-40176.
10. Kooij TW, Janse CJ, Waters AP. 2006. Plasmodium post-genomics: better the bug you know? Nat. Rev. Microbiol. 4:344-357.
11. O'Donnell RA, Saul A, Cowman AF, Crabb BS. 2000. Functional conservation of the malaria vaccine antigen MSP-119 across distantly related Plasmodium species. Nat. Med. 6:91-95.
12. Sanders PR, Kats LM, Drew DR, O'Donnell RA, O'Neill M, Maier AG, Coppel RL, Crabb BS. 2006. A set of glycosylphosphatidyl inositolanchored membrane proteins of Plasmodium falciparum is refractory to genetic deletion. Infect. Immun. 74:4330-4338.
13. Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, Caler E, Crabtree J, Angiuoli SV, Merino EF, Amedeo P, Cheng Q, Coulson RM, Crabb BS, Del Portillo HA, Essien K, Feldblyum TV, Fernandez-Becerra C, Gilson PR, Gueye AH, Guo X, Kang'a S, Kooij TW, Korsinczky M, Meyer EV, Nene V, Paulsen I, White O, Ralph SA, Ren Q, Sargeant TJ, Salzberg SL, Stoeckert CJ, Sullivan SA, Yamamoto MM, Hoffman SL, Wortman JR, Gardner MJ, Galinski MR, Barnwell JW, Fraser-Liggett CM. 2008. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 455:757-763.
14. Woodberry T, Minigo G, Piera KA, Hanley JC, de Silva HD, Salwati E, Kenangalem E, Tjitra E, Coppel RL, Price RN, Anstey NM, Plebanski M. 2008. Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and crossreactive responses. J. Infect. Dis. 198:134-142.
15. Valderrama-Aguirre A, Quintero G, Gomez A, Castellanos A, Perez Y, Mendez F, Arevalo-Herrera M, Herrera S. 2005. Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit. Am. J. Trop. Med. Hyg. 73:16-24.
16. Martinez P, Suarez CF, Gomez A, Cardenas PP, Guerrero JE, Patarroyo MA. 2005. High level of conservation in Plasmodium vivax merozoite surface protein 4 (PvMSP4). Infect. Genet. Evol. 5:354-361.
17. Garzon-Ospina D, Romero-Murillo L, Tobon LF, Patarroyo MA. 2011. Low genetic polymorphism of merozoite surface proteins 7 and 10 in Colombian Plasmodium vivax isolates. Infect. Genet. Evol. 11:528-531.
18. Perez-Leal O, Sierra AY, Barrero CA, Moncada C, Martinez P, Cortes J, Lopez Y, Torres E, Salazar LM, Patarroyo MA. 2004. Plasmodium vivax merozoite surface protein 8 cloning, expression, and characterisation. Biochem. Biophys. Res. Commun. 324:1393-1399.
19. Li J, Ito D, Chen JH, Lu F, Cheng Y, Wang B, Ha KS, Cao J, Torii M, Sattabongkot J, Tsuboi T, Han ET. 2012. Pv12, a 6-Cys antigen of Plasmodium vivax, is localized to the merozoite rhoptry. Parasitol. Int. 426:1-6.
20. Mongui A, Angel DI, Gallego G, Reyes C, Martinez P, Guhl F, Patarroyo MA. 2009. Characterization and antigenicity of the promising vaccine candidate Plasmodium vivax 34 kDa rhoptry antigen (Pv34). Vaccine 28:415-421.
21. Mongui A, Angel DI, Guzman C, Vanegas M, Patarroyo MA. 2008. Characterisation of the Plasmodium vivax Pv38 antigen. Biochem. Biophys. Res. Commun. 376:326-330.
22. Perera KL, Handunnetti SM, Holm I, Longacre S, Mendis K. 1998. Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria. Infect. Immun. 66:1500-1506.
23. Polley SD, McRobert L, Sutherland CJ. 2004. Vaccination for vivax malaria: targeting the invaders. Trends Parasitol. 20:99-102.
24. Han HJ, Park SG, Kim SH, Hwang SY, Han J, Traicoff J, Kho WG, Chung JY. 2004. Epidermal growth factor-like motifs 1 and 2 of Plasmodium vivax merozoite surface protein 1 are critical domains in erythrocyte invasion. Biochem. Biophys. Res. Commun. 320:563-570.
25. Dutta S, Ware LA, Barbosa A, Ockenhouse CF, Lanar DE. 2001. Purification, characterization, and immunogenicity of a disulfide crosslinked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli. Infect. Immun. 69:5464-5470.
26. Wang Y, Kaneko O, Sattabongkot J, Chen JH, Lu F, Chai JY, Takeo S, Tsuboi T, Ayala FJ, Chen Y, Lim CS, Han ET. 2010. Genetic polymorphism of Plasmodium vivax msp1p, a paralog of merozoite surface protein 1, from worldwide isolates. Am. J. Trop. Med. Hyg. 84:292-297.
27. Chen JH, Jung JW, Wang Y, Ha KS, Lu F, Lim CS, Takeo S, Tsuboi T, Han ET. 2010. Immunoproteomics profiling of blood stage Plasmodium vivax infection by high-throughput screening assays. J. Proteome Res. 9:6479-6489.
28. Rui E, Fernandez-Becerra C, Takeo S, Sanz S, Lacerda MV, Tsuboi T, del Portillo HA. 2011. Plasmodium vivax: comparison of immunogenicity among proteins expressed in the cell-free systems of Escherichia coli and wheat germ by suspension array assays. Malar. J. 10:192.
29. Tsuboi T, Takeo S, Iriko H, Jin L, Tsuchimochi M, Matsuda S, Han ET, Otsuki H, Kaneko O, Sattabongkot J, Udomsangpetch R, Sawasaki T, Torii M, Endo Y. 2008. Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect. Immun. 76:1702-1708.
30. Tsuboi T, Takeo S, Sawasaki T, Torii M, Endo Y. 2010. An efficient approach to the production of vaccines against the malaria parasite. Methods Mol. Biol. 607:73-83.
31. Arumugam TU, Takeo S, Yamasaki T, Thonkukiatkul A, Miura K, Otsuki H, Zhou H, Long CA, Sattabongkot J, Thompson J, Wilson DW, Beeson JG, Healer J, Crabb BS, Cowman AF, Torii M, Tsuboi T. 2011. Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen. Infect. Immun. 79:4523-4532.
32. Chen JH, Wang Y, Ha KS, Lu F, Suh IB, Lim CS, Park JH, Takeo S, Tsuboi T, Han ET. 2011. Measurement of naturally acquired humoral immune responses against the C-terminal region of the Plasmodium vivax MSP1 protein using protein arrays. Parasitol. Res. 109:1259-1266.
33. Michon P, Fraser T, Adams JH. 2000. Naturally acquired and vaccineelicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein. Infect. Immun. 68:3164-3171.
34. Mayer DC, Cofie J, Jiang L, Hartl DL, Tracy E, Kabat J, Mendoza LH, Miller LH. 2009. Glycophorin B is the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand, EBL-1. Proc. Natl. Acad. Sci. U. S. A. 106:5348-5352.
35. Arakawa T, Tsuboi T, Kishimoto A, Sattabongkot J, Suwanabun N, Rungruang T, Matsumoto Y, Tsuji N, Hisaeda H, Stowers A, Shimabukuro I, Sato Y, Torii M. 2003. Serum antibodies induced by intranasal immunization of mice with Plasmodium vivax Pvs25 co-administered with cholera toxin completely block parasite transmission to mosquitoes. Vaccine 21:3143-3148.
36. Babon JJ, Morgan WD, Kelly G, Eccleston JF, Feeney J, Holder AA. 2007. Structural studies on Plasmodium vivax merozoite surface protein-1. Mol. Biochem. Parasitol. 153:31-40.
37. Bozdech Z, Mok S, Hu G, Imwong M, Jaidee A, Russell B, Ginsburg H, Nosten F, Day NP, White NJ, Carlton JM, Preiser PR. 2008. The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc. Natl. Acad. Sci. U. S. A. 105:16290-16295.
38. Soares IS, Levitus G, Souza JM, Del Portillo HA, Rodrigues MM. 1997. Acquired immune responses to the N-and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria. Infect. Immun. 65:1606-1614.
39. Fernandez-Becerra C, Sanz S, Brucet M, Stanisic DI, Alves FP, Camargo EP, Alonso PL, Mueller I, del Portillo HA. 2010. Naturally-acquired humoral immune responses against the N-and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay. Malar. J. 9:29.
40. Ceravolo IP, Sanchez BA, Sousa TN, Guerra BM, Soares IS, Braga EM, McHenry AM, Adams JH, Brito CF, Carvalho LH. 2009. Naturally acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein are short-lived and allele-specific following a single malaria infection. Clin. Exp. Immunol. 156:502-510.
41. Grimberg BT, Udomsangpetch R, Xainli J, McHenry A, Panichakul T, Sattabongkot J, Cui L, Bockarie M, Chitnis C, Adams J, Zimmerman PA, King CL. 2007. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med. 4:e337. doi:10.1371/journal.pmed.0040337.
42. Chitnis CE, Miller LH. 1994. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J. Exp. Med. 180:497-506.
43. Chitnis CE, Sharma A. 2008. Targeting the Plasmodium vivax Duffybinding protein. Trends Parasitol. 24:29-34.
44. Goel VK, Li X, Chen H, Liu SC, Chishti AH, Oh SS. 2003. Band 3 is a host receptor binding merozoite surface protein 1 during the Plasmodium falciparum invasion of erythrocytes. Proc. Natl. Acad. Sci. U. S. A. 100: 5164-5169.
45. Li X, Chen H, Oo TH, Daly TM, Bergman LW, Liu SC, Chishti AH, Oh SS. 2004. A co-ligand complex anchors Plasmodium falciparum merozoites to the erythrocyte invasion receptor band 3. J. Biol. Chem. 279:5765-5771.